An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines. (January 2022)
- Record Type:
- Journal Article
- Title:
- An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines. (January 2022)
- Main Title:
- An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines
- Authors:
- Love, Mitchell
Staggs, Jordan
Walters, Corbin
Wayant, Cole
Torgerson, Trevor
Hartwell, Micah
Anderson, J. Michael
Lillie, Anna
Myers, Kate
Brachtenbach, Travis
Derby, Micah
Vassar, Matt - Abstract:
- Graphical abstract: Highlights: Used Systematic reviews in NCCN Detection, Prevention, and Risk Reduction guidelines. No high quality systematic reviews were found via the AMSTAR-2 assessment. Inconsistent adherence to PRISMA was found in included systematic reviews. Uncertain methodology underpinning NCCN guideline recommendations and evidence exists. Abstract: Objective: This study assesses the quality and completeness of systematic reviews (SRs) included by the National Comprehensive Cancer Network (NCCN) cancer screening clinical practice guidelines (CPGs). Methods: We evaluated SRs according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR-2 (A Measurement Tool to Assess systematic Reviews). Results: Seven NCCN CPGs were included with 109 SRs. The mean PRISMA percent completeness of included SRs was 71 % (range 0.1–1.0). The mean AMSTAR-2 percent completeness was 56 % (range 0.05−0.99). Of the 70 SRs assessed via AMSTAR-2, 42 (60 %) received a "critically low" rating, 11 (15.7 %) received "low" ratings, and 17 (24.3 %) received "moderate". None of the SRs received a "high" rating. Conclusion: Lack of adherence to AMSTAR-2 and PRISMA reporting standards among the SRs included is prevalent. We suggest improved reporting of SR inclusion criteria and evaluation to bolster the reporting quality of SRs underpinning CPG recommendations.
- Is Part Of:
- Critical reviews in oncology/hematology. Volume 169(2022)
- Journal:
- Critical reviews in oncology/hematology
- Issue:
- Volume 169(2022)
- Issue Display:
- Volume 169, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 169
- Issue:
- 2022
- Issue Sort Value:
- 2022-0169-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-01
- Subjects:
- Cancer screening -- Clinical practice guidelines -- PRISMA -- AMSTAR-2 -- Systematic reviews
Oncology -- Periodicals
Hematology -- Periodicals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10408428 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.critrevonc.2021.103549 ↗
- Languages:
- English
- ISSNs:
- 1040-8428
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3487.479000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20354.xml